Arcutis Biotherapeutics Inc — Balance Sheet (NASDAQ:ARQT) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Total assets 298.27 M408.15 M449.27 M341.37 M348.89 M432.97 M Total liabilities 27.65 M110.47 M239.69 M252.7 M191.35 M243.49 M Total equity 270.62 M297.68 M209.58 M88.67 M157.54 M189.48 M Total liabilities & shareholders' equities 298.27 M408.15 M449.27 M341.37 M348.89 M432.97 M Total debt —————— Net debt ——————

Haberler

Miners Barrick, Pan American Leads 10 Hot Growth Stocks Onto The IBD 50, Other Premium Lists

Stock Market Can't Hold Key Levels Amid AI Concerns; Nvidia Tumbles Despite Strong Earnings: Weekly Review

Drug Stocks Lead Eight Hot New Names Onto IBD 50 List, Big Cap 20 And More

Needham, Arcutis hissesi için hedef fiyatı güçlü satışlarla 36 dolara yükseltti

Needham raises Arcutis stock price target to $36 on strong sales

Güçlü Zoryve satışları sonrası Arcutis hisse hedefi yükseltildi

H.C. Wainwright raises Arcutis stock price target on strong Zoryve sales

Arcutis Biotherapeutics, Inc. (ARQT) Surpasses Q4 Earnings and Revenue Estimates

Arcutis 4Ç 2025 sonuçları: ZORYVE karlılığı artırıyor

Arcutis Q4 2025 slides: ZORYVE drives profitability, revenue beats

Dow Jones Futures Fall Despite Strong Nvidia Earnings After S&P 500 Reclaims Key Level

Arcutis earnings beat by $0.05, revenue topped estimates